Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Shares Outstanding (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Shares Outstanding for 4 consecutive years, with $57.0 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 49.32% to $57.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $57.0 million through Dec 2025, up 49.32% year-over-year, with the annual reading at $57.0 million for FY2025, 49.32% up from the prior year.
  • Shares Outstanding for Q4 2025 was $57.0 million at Orchestra BioMed Holdings, up from $56.5 million in the prior quarter.
  • The five-year high for Shares Outstanding was $57.0 million in Q4 2025, with the low at $10.1 million in Q1 2022.
  • Average Shares Outstanding over 4 years is $34.2 million, with a median of $35.8 million recorded in 2023.
  • The sharpest move saw Shares Outstanding soared 213.13% in 2023, then rose 0.23% in 2024.
  • Over 4 years, Shares Outstanding stood at $35.7 million in 2022, then rose by 0.23% to $35.8 million in 2023, then grew by 6.76% to $38.2 million in 2024, then soared by 49.32% to $57.0 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $57.0 million, $56.5 million, and $38.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.